“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not result in tolerance with chronic use,” suggests Stahl, a senior team scientist during the Bohn lab. “This can be a desirable element for prospective use from the context of Persistent, serious suffering.”– Compared with most opioids, SR-17018 has